These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

373 related articles for article (PubMed ID: 19122030)

  • 1. Longitudinal prognostic value of serum "free" copper in patients with Alzheimer disease.
    Squitti R; Bressi F; Pasqualetti P; Bonomini C; Ghidoni R; Binetti G; Cassetta E; Moffa F; Ventriglia M; Vernieri F; Rossini PM
    Neurology; 2009 Jan; 72(1):50-5. PubMed ID: 19122030
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictive utility of apolipoprotein E genotype for Alzheimer disease in outpatients with mild cognitive impairment.
    Devanand DP; Pelton GH; Zamora D; Liu X; Tabert MH; Goodkind M; Scarmeas N; Braun I; Stern Y; Mayeux R
    Arch Neurol; 2005 Jun; 62(6):975-80. PubMed ID: 15956169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evolution of blood pressure in patients with Alzheimer's disease: a one year survey of a French Cohort (REAL.FR).
    Hanon O; Latour F; Seux ML; Lenoir H; Forette F; Rigaud AS;
    J Nutr Health Aging; 2005; 9(2):106-11. PubMed ID: 15791354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of rapid decline in mini mental state examination in clinical practice for prognosis in Alzheimer's disease.
    Soto ME; Andrieu S; Cantet C; Reynish E; Ousset PJ; Arbus C; Gillette-Guyonnet S; Nourhashémi F; Vellas B;
    Dement Geriatr Cogn Disord; 2008; 26(2):109-16. PubMed ID: 18617740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free copper distinguishes mild cognitive impairment subjects from healthy elderly individuals.
    Squitti R; Ghidoni R; Scrascia F; Benussi L; Panetta V; Pasqualetti P; Moffa F; Bernardini S; Ventriglia M; Binetti G; Rossini PM
    J Alzheimers Dis; 2011; 23(2):239-48. PubMed ID: 20930297
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is cognitive function linked to serum free copper levels? A cohort study in a normal population.
    Salustri C; Barbati G; Ghidoni R; Quintiliani L; Ciappina S; Binetti G; Squitti R
    Clin Neurophysiol; 2010 Apr; 121(4):502-7. PubMed ID: 20097602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A longitudinal study of Alzheimer's disease: rates of cognitive and functional decline.
    Suh GH; Ju YS; Yeon BK; Shah A
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):817-24. PubMed ID: 15352138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognitive status correlates with neuropathologic stage in Parkinson disease.
    Braak H; Rüb U; Jansen Steur EN; Del Tredici K; de Vos RA
    Neurology; 2005 Apr; 64(8):1404-10. PubMed ID: 15851731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Value of serum nonceruloplasmin copper for prediction of mild cognitive impairment conversion to Alzheimer disease.
    Squitti R; Ghidoni R; Siotto M; Ventriglia M; Benussi L; Paterlini A; Magri M; Binetti G; Cassetta E; Caprara D; Vernieri F; Rossini PM; Pasqualetti P
    Ann Neurol; 2014 Apr; 75(4):574-80. PubMed ID: 24623259
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comprehensive geriatric assessment in female elderly patients with Alzheimer disease and other types of dementia.
    Riccio D; Solinas A; Astara G; Mantovani G
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():343-53. PubMed ID: 17317473
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is functional decline necessary for a diagnosis of Alzheimer's disease?
    Park KW; Pavlik VN; Rountree SD; Darby EJ; Doody RS
    Dement Geriatr Cogn Disord; 2007; 24(5):375-9. PubMed ID: 17914262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rate of progression differs in frontotemporal dementia and Alzheimer disease.
    Rascovsky K; Salmon DP; Lipton AM; Leverenz JB; DeCarli C; Jagust WJ; Clark CM; Mendez MF; Tang-Wai DF; Graff-Radford NR; Galasko D
    Neurology; 2005 Aug; 65(3):397-403. PubMed ID: 16087904
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease.
    Sanz C; Andrieu S; Sinclair A; Hanaire H; Vellas B;
    Neurology; 2009 Oct; 73(17):1359-66. PubMed ID: 19858457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CSF biomarkers predict rate of cognitive decline in Alzheimer disease.
    Kester MI; van der Vlies AE; Blankenstein MA; Pijnenburg YA; van Elk EJ; Scheltens P; van der Flier WM
    Neurology; 2009 Oct; 73(17):1353-8. PubMed ID: 19858456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Excess of nonceruloplasmin serum copper in AD correlates with MMSE, CSF [beta]-amyloid, and h-tau.
    Squitti R; Barbati G; Rossi L; Ventriglia M; Dal Forno G; Cesaretti S; Moffa F; Caridi I; Cassetta E; Pasqualetti P; Calabrese L; Lupoi D; Rossini PM
    Neurology; 2006 Jul; 67(1):76-82. PubMed ID: 16832081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stem cell factor plasma levels are decreased in Alzheimer's disease patients with fast cognitive decline after one-year follow-up period: the Pythia-study.
    Laske C; Sopova K; Hoffmann N; Stransky E; Hagen K; Fallgatter AJ; Stellos K; Leyhe T
    J Alzheimers Dis; 2011; 26(1):39-45. PubMed ID: 21593573
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A qualitative analysis of the mini mental state examination on Alzheimer's disease patients treated with cholinesterase inhibitors.
    Lucchi E; Minicuci N; Magnifico F; Mondini S; Calza A; Avanzi S; Villani D; Bellelli G; Trabucchi M
    Arch Gerontol Geriatr Suppl; 2004; (9):253-63. PubMed ID: 15207422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2.
    Plastino M; Fava A; Pirritano D; Cotronei P; Sacco N; Sperlì T; Spanò A; Gallo D; Mungari P; Consoli D; Bosco D
    J Neurol Sci; 2010 Jan; 288(1-2):112-6. PubMed ID: 19836029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of cognitive change from preclinical to clinical Alzheimer's disease.
    Jones S; Small BJ; Fratiglioni L; Backman L
    Brain Cogn; 2002 Jul; 49(2):210-3. PubMed ID: 15259392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.